Pages that link to "Q43005397"
Jump to navigation
Jump to search
The following pages link to Complete regression of advanced HCC with long acting octreotide (Q43005397):
Displaying 7 items.
- Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action (Q27693179) (← links)
- Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide (Q33213123) (← links)
- The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets (Q34182483) (← links)
- Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial (Q35621231) (← links)
- Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken. (Q37084269) (← links)
- Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma (Q49168467) (← links)
- Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma (Q79886534) (← links)